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Instructions to Authors
The ofﬁ cial journal of the Japanese College of Cardiology is an international, English language, 
peer-reviewed journal publishing the latest ﬁ ndings in cardiovascular medicine. The Journal of 
Cardiology (JC) aims to publish the highest-quality material covering original basic and clinical research 
on all aspects of cardiovascular disease. Topics covered include ischemic heart disease, cardiomyopathy, 
valvular heart disease, vascular disease, hypertension, arrhythmia, congenital heart disease, pharma-
cological and non-pharmacological treatment, new diagnostic techniques, and cardiovascular imaging. 
JC also publishes a selection of review articles, clinical trials, short communications, and important 
messages and letters to the editor.
Case Reports will be published online in the Journal of Cardiology Cases (JC Cases) which is planned 
to be launched in 2010.
JC will receive materials prepared and submitted according to these instructions. However, we reserve 
the right to make any changes necessary to make the contribution conform to the editorial standards of 
the journal, as deemed by the Editorial Board based on the recommendations of the reviewers.
Any contributions accepted for publication will become the copyright of this journal. No responsibility is 
assumed by the Editorial Board for the opinions or the ethics expressed by the contributors. The work shall 
not be published in any other publication in any language without prior written consent of the publisher.
Submission to JC now proceeds online via Elsevier Editorial System - http://ees.elsevier.com/jjcc. 
Authors will be guided step-by-step through uploading ﬁ les directly from their computers. Electronic PDF 
proofs will be automatically generated from uploaded ﬁ les, and used for subsequent reviewing.
Authors submitting hard copy papers will usually be asked to resubmit using Elsevier Editorial System. The 
Editor-in-Chief may occasionally allow hard copy submissions of some components of an article; please 
contact him should you consider this necessary, and send any such items to:
Editor-in-Chief, Journal of Cardiology
c/o Elsevier Japan, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan
Fax: +81 3 3589 6364, Tel: +81 3 3589 5037
E-mail: jp.jjcc@elsevier.com
Global telephone support is available for e-submission 24/7. A comprehensive Author Support service is 
also available to answer additional enquiries at authorsupport@elsevier.com
For The Americas: +1 888 834 7287 (toll-free for US & Canadian customers)
For Asia & Paciﬁ c: +81 3 5561 5032
For Europe & rest of the world: +353 61 709190
Copyright
Submission of an article is understood to imply that the article is original and is not being considered 
for publication elsewhere. Upon acceptance of the article by the journal, the author(s) will be asked 
to transfer the copyright of the article to the publisher. This transfer will ensure the widest possible 
dissemination of information.
Multiple authorship
On submission, all authors of the paper listed should sign a letter in which they state that they all have 
participated sufﬁ ciently in the conception and design of the work, in the analysis of the data and in writing 
the manuscript to take public responsibility for it.
Ethical standards
Human subject experiments or the usage of human materials (such as tissues) should be in accordance 
with the ethical standards of a responsible committee at the institute where the research is carried out 
and with the Helsinki Declaration. Patients should be referred to by number; do not use real names, 
initials or hospital numbers. Animal studies should be carried out within recognised guidelines for the 
care of laboratory animals.
Categories of manuscripts
Original Articles. These may describe original clinical or laboratory research. The length should ordinarily 
be less than 4,000 words, with no more than a total of 8 tables and ﬁ gures.
Reviews. Reviews may concern either clinical or laboratory scientiﬁ c topics. Relatively brief reviews of 
between 3,500 and 4,000 words are particularly welcome. Longer reviews are acceptable when justiﬁ ed 
by topic and comprehensiveness. The maximum length should be less than 5,000 words, with no more 
than a total of 8 tables and ﬁ gures.
Case Reports. This type of article is to be published online in the Journal of Cardiology Cases (JC Cases) 
to be launched by the Society in 2010. A case report should describe a new disease, or conﬁ rmation of a 
rare or new disease; a new insight into pathogenesis, etiology, diagnosis, or treatment; or a new ﬁ nding 
associated with a currently known disease. A report of special scientiﬁ c investigation, even in a single 
patient, will be regarded as an original article. The length should ordinarily be less than 1,500 words, 
with no more than a total of 3 tables and ﬁ gures and 10 references. This can be exceeded only when 
justiﬁ ed by extensive special studies.
Letters to the Editor. These should be up to 1,000 words in length, and should be submitted in response 
to material published in the journal to make small clinical points or to introduce a point of view. They 
can be accompanied by up to 5 references but no illustrations.
Manuscript format
Title page. All manuscripts must be covered with a title page including the title (within 25 words), type of 
article and 3 to 6 keywords. The authors’ full and complete names, degrees, and institutions should be given on 
the title page, as well as full postal address, telephone/fax numbers, and e-mail address for correspondence.
Abstract. Brieﬂ y state the summary of the text within 300 words in a structured format (Case Report: 
within 200 words in a non-structured format). The background and purpose, methods and subjects, 
essential results, and the principal conclusions should be included. The abstract may be re-published by 
information retrieval services in another forum.
Introduction. Clearly and brieﬂ y describe the background and the rational objective of the study, with 
a review of earlier publications. It is recommended that the previous studies described only be the most 
relevant. Avoid exhaustive review of the literature.
Materials and Methods/Case Histories. Clearly describe the subjects  and sample size, the experimental 
procedures and apparatus (manufacturer’s name and address) used in the study. In the case of experi-
ments on human or animal subjects, give an account that the methods were regarded as ethically sound. 
In the event of an original design, the details should be provided. Otherwise, references accompanied 
by sufﬁ cient information for interdisciplinary evaluation will sufﬁ ce. The type of statistical analysis 
used must be stated in this section as well as the commercial software. Do not include discussion in this 
section. Demonstrate precisely all drugs and chemicals used, including generic names, doses and routes 
of administration.
Results. Present the essential results in the text in a clear and concise manner. Use tables and ﬁ gures to 
compare and contrast the ﬁ ndings. Do not repeat in the text all the detailed data in the tables or ﬁ gures. 
Do not include discussion in this section. In describing the statistical analysis, please deﬁ ne the probability 
values and prove that the differences reported were found to be statistically signiﬁ cant.
Discussion. Demonstrate the objective reliability of the results as well as the propriety and limitations of the 
experimental procedures and subjects used. Point out the signiﬁ cance and the limitations of the study, including 
implications for future research. Describe and evaluate the results with a scientiﬁ cally critical view, and 
discuss your ﬁ ndings in the context of other publications, including opposing views. The introduction or 
the details of the results should not be repeated in this section. Subjective comments can be made only 
in this section, however, speculation must be identiﬁ ed as such. Link the conclusions with the objectives 
of the study, as stated in the introduction.
Acknowledgments. Acknowledgments, the scientiﬁ c meeting at which the data has already been 
presented, the sources of funding for the study, and/or any other special mention may be stated before 
the References section.
References. All publications cited in the text should be presented in a list of references following the 
text of the manuscript. References should be numbered consecutively in the order in which they are ﬁ rst 
mentioned. In the text they should be cited with Arabic numerals between square brackets. For listing 
references, follow the Vancouver style, abbreviating names of journals according to the index in PubMed. 
List all authors/editors but if there are more than ﬁ fteen, list ﬁ rst ﬁ fteen plus et al.
Examples:
[1]  Matsumura K, Kubota S, Serizawa T, Nakase E. Coronary hemodynamics in vasospastic angina: 
Quantitative analysis by digital subtraction angiography. J Cardiol 1991;21:507—516 (in Japanese).
[2]  Braunwald E. Pathology of pulmonary embolism. In: Braunwald E, editor. Heart disease: A textbook 
of cardiovascular medicine. 5th ed. Philadelphia: WB Saunders; 1997. p. 1582—1585.
Tables. Tables should be submitted online as a separate ﬁ le, bear a concise title, and be numbered with 
Arabic numerals. Tables should be cited in the text. Column headings should be brief, but sufﬁ ciently 
explanatory. Standard abbreviations of units of measurement should be added between parentheses. 
Vertical lines should not be used to separate columns.
Figures. Written permission must be obtained and supplied from the original author(s) and the original 
publisher (copyright holder) for the use of any ﬁ gures, charts, graphs, and tables previously published in 
other journals or books either by reproduction or with any modiﬁ cation. Credit must be given in legends 
and/or text for borrowed materials.
•  The number of ﬁ gures used to present data essential to illustrate or prove a point should be kept to 
a minimum.
•  Reference should be made in the text to each illustration. Figures will be reduced to ﬁ t to the size of 
one column (8.5 cm) or two columns (17.5 cm), and any lettering should be large enough to allow this 
reduction without becoming illegible
•  Each ﬁ gure should be accompanied by a title and an explanatory legend on a separate page called 
Legends to Figures. There should be sufﬁ cient experimental details in the legend to make the ﬁ gure 
intelligible without reference to the text
•  Legends to Figures should be typed double-spaced, in numerical order, on a separate page
•  Photographs should be as high in contrast as possible
•  Indicate the magniﬁ cation of photomicrographs in bar scales on the illustration itself instead of numerical 
magniﬁ cation factors
•  Make sure you use uniform lettering and sizing of your original artwork
•  Save text in illustrations as “graphics” or enclose the font
•  Only use the following fonts in your illustrations: Arial, Courier, Helvetica, Times, Symbol
•  Number the illustrations according to their sequence in the text
•  Use a logical naming convention for your artwork ﬁ les
•  Provide all illustrations as separate ﬁ les
•  Provide captions to illustrations separately
•  Produce images near to the desired size of the printed version
A detailed guide on electronic artwork is available on our website: 
http://www.elsevier.com/artwork instructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats:
Regardless of the application used, when your electronic artwork is ﬁ nalised, please “save as” or convert 
the images to one of the following formats (Note the resolution requirements for line drawings, halftones, 
and line/halftone combinations given below.):
EPS: Vector drawings. Embed the font or save the text as “graphics”.
TIFF: Colour or greyscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (colour or greyscale): a minimum of 500 dpi is required.
DOC, XLS or PPT:  If your electronic artwork is created in any of these Microsoft Ofﬁ ce applications 
please supply “as is” (in native format).
Please do not:
•  Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document
•  Supply ﬁ les that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low
•  Supply ﬁ les that are too low in resolution
•  Submit graphics that are disproportionately large for the content
If, together with your accepted article, you submit usable colour ﬁ gures, Elsevier will ensure that these 
ﬁ gures will appear in colour completely free-of-charge in the electronic version of your paper, regardless 
of whether or not these illustrations are reproduced in colour in the printed version. Colour illustrations 
can only be included in print if the additional cost of reproduction (EUR 300 for the ﬁ rst page, and EUR 
200 for the second and subsequent pages) is contributed by the author: you will receive information 
regarding the costs from Elsevier after receipt of your accepted article. Please note that because of 
technical complications which may arise by converting colour ﬁ gures to ‘grey scale’ (for the printed 
version, should you not opt for colour in print), you should submit in addition usable black and white 
version ﬁ les corresponding to all the colour illustrations.
Supplementary data. JC accepts electronic supplementary material such as high-resolution images, 
background datasets, sound clips, video material, animation sequences and more to support and enhance 
your scientiﬁ c research and to evade the limit of manuscript length. Supplementary ﬁ les supplied will be 
published online alongside the electronic version of your article. For more detailed instructions please 
visit our artwork instruction pages at  http://www.elsevier.com/artworkinstructions. Authors should 
submit the material as an e-component in electronic format together with the article and supply a 
concise and descriptive caption for each ﬁ le.
Correspondence
All contributions and all communications relating to the publication should be addressed to:
 Editor-in-Chief of Journal of Cardiology
 c/o Elsevier Japan, 1-9-15 Higashi-Azabu, Minato-ku, Tokyo 106-0044, Japan
 Fax: +81-3-3589-6364
 e-mail: jp.jjcc@elsevier.com
Author rights
As an author you (or your employer or institution) may do the following:
-  make copies (print or electronic) of the article for your own personal use, including for your own class-
room teaching use
-  make copies and distribute such copies (including through e-mail) of the article to research colleagues, 
for the personal use by such colleagues (but not commercially or systematically, e.g., via an e-mail list 
or list server)
-  post a pre-print version of the article on Internet websites including electronic pre-print servers, and 
to retain indeﬁ nitely such version on such servers or sites
-  post a revised personal version of the ﬁ nal text of the article (to reﬂ ect changes made in the peer 
review and editing process) on your personal or institutional website or server, with a link to the journal 
homepage (on elsevier.com)
-  present the article at a meeting or conference and to distribute copies of the article to the delegates 
attending such a meeting
-  for your employer, if the article is a ‘work for hire’, made within the scope of your employment, your 
employer may use all or part of the information in the article for other intra-company use (e.g., training)
-  retain patent and trademark rights and rights to any processes or procedure described in the article
-  include the article in full or in part in a thesis or dissertation (provided that this is not to be published 
commercially)
-  use the article or any part thereof in a printed compilation of your works, such as collected writings or 
lecture notes (subsequent to publication of your article in the journal)
-  prepare other derivative works, to extend the article into book-length form, or to otherwise re-use 
portions or excerpts in other works, with full acknowledgement of its original publication in the journal
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors who publish in Elsevier 
journals to comply with potential manuscript archiving requirements as speciﬁ ed as conditions of their 
grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.
com/fundingbodies
US National Institutes of Health (NIH) voluntary posting (“ Public Access”) policy
Elsevier facilitates author response to the NIH voluntary posting request (referred to as the NIH “Public 
Access Policy”; see http://publicaccess.nih.gov/) by posting the peer-reviewed author’s manuscript 
directly to PubMed Central on request from the author, 12 months after formal publication. Upon 
notiﬁ cation from Elsevier of acceptance, we will ask you to conﬁ rm via e-mail (by e-mailing us at 
NIHauthorrequest@elsevier.com) that your work has received NIH funding and that you intend to respond 
to the NIH policy request, along with your NIH award number to facilitate processing. Upon such conﬁ rmation, 
Elsevier will submit to PubMed Central on your behalf a version of your manuscript that will include peer-review 
comments, for posting 12 months after formal publication. This will ensure that you will have responded 
fully to the NIH request policy. There will be no need for you to post your manuscript directly with 
PubMed Central, and any such posting is prohibited.
Proofs and offprints
Proofs will be sent to the corresponding author together with the offprint order form. If an e-mail address 
is supplied, proofs will be sent as e-mail attachment in PDF format, together with instructions. Authors 
are requested to return corrections by e-mail or fax within 48 hours. Authors will be charged for extensive 
alterations in the proofs. Twenty-ﬁ ve free offprints of each article will be supplied. Additional offprints 
can be ordered at the price shown on the offprint order form.
Journal of Cardiology does not have page charges.
